Insights in Multiple Sclerosis (MS) and Neuroimmunology: 2nd Edition

Dear Colleagues,

This Special Issue is a continuation of our previous Special Issue on “Insights in Multiple Sclerosis (MS) and Neuroimmunology”.

Neurodegeneration, defined as damage to neurons, oligodendrocytes, and axons, is now acknowledged to be the primary driver of disability in multiple sclerosis (MS) patients. Therefore, research into the mechanisms of neurodegeneration in MS has expanded over the past several years. Furthermore, with the development and implementation of more precise technologies, including sequencing and advanced imaging, we can more confidently define processes that cause damage to neurons, oligodendrocytes, and axons in MS.

For this Special Issue on ‘Insights in Multiple Sclerosis (MS) and Neuroimmunology’, we accept both reviews and original articles that explore the mechanisms of neurodegeneration, including those with an immunological mediator (i.e., macrophages, T-cells, B-cells, astrocytes, etc.). Reviews should highlight the most recent findings with regard to this topic, as well as emphasize novel approaches that are helping to advance this area of research. Original articles should demonstrate potential mechanisms of neurodegeneration, including damage to neurons, oligodendrocytes, and axons, in any MS models, including in vitro, in vivo, and in situ systems with a particular emphasis on immunological mediators. Original articles may also include potential therapies to combat neurodegeneration in MS.

This Special Issue is supervised by Prof. Dr. Michael C. Levin and assisted by Dr. Catherine Hutchinson. We warmly welcome the submission of short communications, original research articles, and review articles.

Prof. Dr. Michael C. Levin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• neurodegeneration
• neuroimmunology
• macrophage
• T-cell
• B-cell
• antibody
• neurons
• oligodendrocytes
• axon
• axonal damage
• cell death
• multiple sclerosis